Frank Takkinen
Stock Analyst at Lake Street
(0.91)
# 3,935
Out of 5,179 analysts
77
Total ratings
25.71%
Success rate
-16.79%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TELA TELA Bio | Maintains: Buy | $3 → $2 | $0.67 | +198.46% | 4 | Mar 25, 2026 | |
| HYPR Hyperfine | Maintains: Buy | $2 → $2.5 | $1.11 | +125.23% | 3 | Mar 19, 2026 | |
| TNDM Tandem Diabetes Care | Upgrades: Buy | $50 | $21.00 | +138.10% | 1 | Feb 23, 2026 | |
| NOTV Inotiv | Maintains: Buy | $3 → $1.5 | $0.27 | +455.35% | 9 | Feb 10, 2026 | |
| RCEL AVITA Medical | Maintains: Hold | $3 → $3.5 | $3.82 | -8.38% | 2 | Jan 16, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $35 → $40 | $10.76 | +271.75% | 2 | Jan 9, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $6 → $8 | $4.22 | +89.57% | 3 | Dec 22, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $3.88 | +209.28% | 7 | Dec 10, 2025 | |
| AXGN Axogen | Maintains: Buy | $30 → $40 | $31.28 | +27.88% | 2 | Dec 4, 2025 | |
| ADGM Adagio Medical Holdings | Initiates: Buy | $4 | $1.22 | +227.87% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.17 | +241.88% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $1.07 | +460.75% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $150 | $50.13 | +199.22% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $10.90 | +120.18% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $8.91 | +57.13% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $6.07 | +147.12% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $12.95 | +100.77% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $9.07 | +230.76% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $5.19 | +285.36% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.59 | +214.47% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $35.29 | -14.99% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.65 | +819.40% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.82 | +119.78% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $13.34 | -10.04% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.64 | +147.25% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $3.65 | +338.96% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $923 → $277 | $8.67 | +3,093.77% | 2 | Jan 18, 2023 |
TELA Bio
Mar 25, 2026
Maintains: Buy
Price Target: $3 → $2
Current: $0.67
Upside: +198.46%
Hyperfine
Mar 19, 2026
Maintains: Buy
Price Target: $2 → $2.5
Current: $1.11
Upside: +125.23%
Tandem Diabetes Care
Feb 23, 2026
Upgrades: Buy
Price Target: $50
Current: $21.00
Upside: +138.10%
Inotiv
Feb 10, 2026
Maintains: Buy
Price Target: $3 → $1.5
Current: $0.27
Upside: +455.35%
AVITA Medical
Jan 16, 2026
Maintains: Hold
Price Target: $3 → $3.5
Current: $3.82
Upside: -8.38%
Beta Bionics
Jan 9, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $10.76
Upside: +271.75%
KORU Medical Systems
Dec 22, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $4.22
Upside: +89.57%
Sight Sciences
Dec 10, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $3.88
Upside: +209.28%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $31.28
Upside: +27.88%
Adagio Medical Holdings
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $1.22
Upside: +227.87%
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.17
Upside: +241.88%
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.07
Upside: +460.75%
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $50.13
Upside: +199.22%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.90
Upside: +120.18%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $8.91
Upside: +57.13%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $6.07
Upside: +147.12%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $12.95
Upside: +100.77%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $9.07
Upside: +230.76%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $5.19
Upside: +285.36%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.59
Upside: +214.47%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $35.29
Upside: -14.99%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.65
Upside: +819.40%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $1.82
Upside: +119.78%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $13.34
Upside: -10.04%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.64
Upside: +147.25%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $3.65
Upside: +338.96%
Jan 18, 2023
Maintains: Buy
Price Target: $923 → $277
Current: $8.67
Upside: +3,093.77%